Apellis Pharmaceuticals shares owned by Snowden Capital Advisors
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Snowden Capital Advisors
from 13F filings
Historical chart of Snowden Capital Advisors investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Snowden Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Snowden Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $354k | 12k | 28.84 |
| 2024-06-30 | $464k | 12k | 38.36 |
| 2024-03-31 | $523k | 8.9k | 58.78 |
| 2023-12-31 | $548k | 9.2k | 59.86 |
| 2023-09-30 | $360k | 9.5k | 38.04 |
| 2023-06-30 | $550k | 6.0k | 91.10 |
| 2023-03-31 | $386k | 5.9k | 65.96 |
| 2019-06-30 | $277k | 11k | 25.34 |